SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-14-007665
Filing Date
2014-09-16
Accepted
2014-09-16 16:20:18
Documents
3
Period of Report
2014-11-03
Effectiveness Date
2014-09-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2221424zdef14a.htm DEF 14A 262447
2 G208854BII001.JPG g208854bii001.jpg GRAPHIC 78135
3 G208854BII002.GIF g208854bii002.gif GRAPHIC 23145
  Complete submission text file 0001047469-14-007665.txt   403570
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35268 | Film No.: 141105651
SIC: 2834 Pharmaceutical Preparations